A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation
Ling Chen, Guiying Xu, Xiaoxu Song, Lianbo Zhang, Chuyu Chen, Gang Xiang, Shuxuan Wang, Zijian Zhang, Fang Wu, Xuanming Yang, Lei Zhang, Xiaojing Ma, Jing Yu
Topics & Concepts
Cancer researchTriple-negative breast cancerCCR5 receptor antagonistMetastasisCCL5MaravirocTumor microenvironmentYAP1Breast cancerChemokineBiologyCancerMedicineImmunologyChemokine receptorImmune systemInternal medicineTranscription factorT cellHuman immunodeficiency virus (HIV)GeneBiochemistryIL-2 receptorTumor cellsHippo pathway signaling and YAP/TAZImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers